MedWatch

ChemoMetec launches new cell count device

The Danish medtech group ChemoMetec is launching a new product in the hope of reversing a negative development on the Asian market.

Foto: Colourbox

The listed Danish medtech company, ChemoMetec, is launching the latest edition to its portfolio, the cell count device NC-250. The product was scheduled for launch this spring.

According to the company, the NC-250 is a virtually maintenance-free device with very low associated costs. With the launch ChemoMetec expects to increase market shares within the markets for life science research and pharmaceutical quality control and production.

Allerede abonnent? Log ind.

Læs hele artiklen

Få adgang i 14 dage for 0 kr.
Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.

  • Adgang til alle låste artikler
  • Modtag vores daglige nyhedsbreve
  • Fuld adgang til vores app
Der skete en fejl. Prøv venligst igen senere

Få fuld adgang til dig og dine kollegaer.

Start et gratis virksomhedsprøveabonnement

Mere fra MedWatch

Seneste nyt

MedWatch job

Se flere jobs

Se flere jobs

Watch job

Se flere jobs

Se flere jobs

Latest news

Seneste nyt fra Watch Medier